Indian Nivolumab Exporters: Complete Supplier Ranking with Market Share — 47 Manufacturers (2026) — TransData Nexus

Q: Who is the largest nivolumab buyer importing from India?

ALMAC PHARMACEUTICAL SERVICES PTE LIMITED (SINGAPORE) is the largest nivolumab importer from India with a 46.0% market share and import value of $1.1M.

Q: How many nivolumab buyers import from India?

There are 47 active nivolumab buyers importing from India, with a combined import market of $2.3M across 144 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top nivolumab buyers from India?

The top 5 nivolumab buyers — ALMAC PHARMACEUTICAL SERVICES PTE LIMITED, COREX LLC, AS PER INVOICE, STATE TRADING ORGANIZATION PLC, JAIR CARLOS DE ARAUJO — together control 85.9% of total nivolumab import value from India.

Suresh Sormare

Nivolumab

India Pharmaceutical Trade Intelligence

$2.3M23 Suppliers13 CountriesHS 30049099

ExportsIndia → SINGAPORE46.0%India → RUSSIA33.9%

ImportsUNITED STATES → India$48.1B SWITZERLAND → India$15.1M

Market Analysis: Top Importing Countries & Their Importers

1Singapore

Singapore emerges as the first largest importing country, achieving a total trade value of $1.1M through 2 shipments. This represents a market share of 46.0% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Singapore has a diverse importer base, with their top importers including:

• ALMAC PHARMACEUTICAL SERVICES PTE LIMITED - $1.1M (100.0% of country's total business)

Key Insight: Singapore demonstrates strong market positioning with an average shipment value of $525.6K, indicating premium pricing strategy compared to the market average of $15.9K.

Singapore is a key market for Nivolumab imports, representing 46.0% of total trade value.

Primary Market

Secondary Market

2Russia

Russia emerges as the second largest importing country, achieving a total trade value of $773.4K through 8 shipments. This represents a market share of 33.9% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Nivolumab buyer market intelligence

1Buyer Segment Analysis

The importers of Nivolumab from India can be categorized into several key segments:

1. Distributors: Entities like ALMAC PHARMACEUTICAL SERVICES PTE LIMITED in Singapore and COREX LLC in Russia function as intermediaries, procuring Nivolumab in bulk and supplying it to healthcare providers within their respective regions. Their purchasing patterns typically involve large-volume orders to meet the demands of multiple clients.

2. Hospital Groups: Institutions such as INDIRA GANDHI MEMORIAL HOSPITAL in the Maldives directly import Nivolumab to administer to patients within their facilities. Their procurement is often based on patient needs and treatment schedules, leading to periodic, demand-driven orders.

3. Government Procurement Agencies: Organizations like the STATE TRADING ORGANIZATION PLC in the Maldives and HEALTH CARE AGENCY in Seychelles are responsible for national healthcare procurement. They often engage in tender-based purchasing, aiming to secure medications at competitive prices for public health initiatives.

4. Individual Buyers: Entities listed as "AS PER INVOICE" in Brazil and individuals like JAIR CARLOS DE ARAUJO and FRANCISCO EUDES DA SILVA represent personal imports, possibly for specific patient treatments. Their purchasing behavior is typically characterized by smaller, one-time orders.

Understanding these segments is crucial for tailoring market strategies, as each exhibits distinct procurement behaviors and order patterns.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Nivolumab buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Nivolumab are as follows:

1. Singapore:

Regulatory Authority: Health Sciences Authority (HSA).

Import Registration Process: Importers must obtain a product license from the HSA, which involves submitting comprehensive documentation on the drug's quality, safety, and efficacy.

Estimated Timeline for Registration: Approximately 9 to 12 months.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties in Singapore.

2. Russia:

Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires state registration, including submission of a registration dossier and samples for testing.

Demand Drivers & Market Opportunity

TransData Nexus Nivolumab buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Nivolumab in importing countries is driven by several factors:

1. Disease Prevalence: Nivolumab is primarily used in the treatment of various cancers, including melanoma, non-small cell lung cancer, and renal cell carcinoma. The prevalence of these cancers in countries like Singapore, Russia, and Brazil contributes to the consistent demand for this immunotherapy.

2. Government Healthcare Programs: Many importing countries have national healthcare programs that subsidize or fully cover the cost of essential medicines, including cancer treatments. For instance, Brazil's Unified Health System (SUS) provides access to oncology medications, influencing procurement patterns.

3. Universal Health Coverage Expansion: Efforts to expand universal health coverage in countries like the Maldives and Seychelles have led to increased access to advanced therapies, thereby boosting demand for drugs like Nivolumab.

4. WHO Essential Medicines List Procurement: While Nivolumab is not currently listed on the WHO Essential Medicines List, its inclusion in national formularies and treatment guidelines can drive procurement through public health channels.

5. Tender-Based Purchasing: Government and hospital tenders are common procurement methods, especially in countries with centralized healthcare systems. These tenders often result in bulk purchasing agreements, influencing the volume and frequency of Nivolumab imports.

With 47 buyers across 13 countries, the market for Nivolumab imported from India reflects a diverse and expanding landscape, shaped by healthcare policies, disease burden, and procurement practices.

Common Questions — Nivolumab Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest nivolumab buyer importing from India?

Based on import volume and value, ALMAC PHARMACEUTICAL SERVICES PTE LIMITED (SINGAPORE) leads with $1.1M in imports and a 46.0% market share — the highest of any single nivolumab importer. COREX LLC (RUSSIA) and AS PER INVOICE (BRAZIL) are the next largest buyers.

QHow many companies buy nivolumab from India?

There are 47 active nivolumab buyers importing from India, with a combined market of $2.3M across 144 shipments to 13 countries. The top 5 buyers hold 85.9% of total import value, while the remaining 42 buyers handle the other 14.1%.

QWhich countries import the most nivolumab from India?

The top importing countries for nivolumab from India are Singapore (46.0%), Russia (33.9%), Brazil (12.3%), Seychelles (2.5%), Maldives (2.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of nivolumab, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for nivolumab from India?

The average import transaction value for nivolumab from India is $15.9K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Nivolumab buyer market intelligence

1Buyer Segment Analysis

The importers of Nivolumab from India can be categorized into several key segments:

Understanding these segments is crucial for tailoring market strategies, as each exhibits distinct procurement behaviors and order patterns.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Country-Specific Import Regulations

TransData Nexus Nivolumab buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Nivolumab are as follows:

1. Singapore:

Regulatory Authority: Health Sciences Authority (HSA).

Import Registration Process: Importers must obtain a product license from the HSA, which involves submitting comprehensive documentation on the drug's quality, safety, and efficacy.

Estimated Timeline for Registration: Approximately 9 to 12 months.

Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties in Singapore.

2. Russia:

Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires state registration, including submission of a registration dossier and samples for testing.

Demand Drivers & Market Opportunity

TransData Nexus Nivolumab buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Nivolumab in importing countries is driven by several factors:

With 47 buyers across 13 countries, the market for Nivolumab imported from India reflects a diverse and expanding landscape, shaped by healthcare policies, disease burden, and procurement practices.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Nivolumab

Nivolumab

Who Buys Nivolumab from India — 47 Importers Behind a $2.3M Market

Top Nivolumab Importers — Ranked by Import Value

Top Nivolumab Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Nivolumab — and from which countries?

Nivolumab — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Singapore

2Russia

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Nivolumab Buyers & Importers

QWho is the largest nivolumab buyer importing from India?

QHow many companies buy nivolumab from India?

QWhich countries import the most nivolumab from India?

QWhat is the average import order value for nivolumab from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Brazil

4Seychelles

5Maldives

Analysis Methodology